Drugs@FDA document
BICILLIN L-A Letter · NDA 050141 SUPPL-240
Drugs@FDA document · KING PHARMS LLC · May 17, 2021
Key facts
| Drug name | BICILLIN L-A |
|---|---|
| Document type | Letter |
| Application | NDA050141 |
| Submission | SUPPL-240 |
| Company | KING PHARMS LLC |
| Document date | May 17, 2021 |
| FDA document | accessdata.fda.gov |
At a glance
- Manufacturing (CMC)-Packaging Document categories
- 10–99 Documents for this application
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: